Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Mode of Anesthesia on Ischemia Modified Albumin (Abiomarker of Oxidative Stress) and Outcome in Patients With Traumatic Brain Injury Undergoing Emergency Craniotomy

NCT04490122 is registered in ClinicalTrials.gov with Abd-elrahman hassan abd -elaziz as lead sponsor.

NCT NCT04490122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04490122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Mode of Anesthesia on Ischemia Modified Albumin (Abiomarker of Oxidative Stress) and Outcome in Patients With Traumatic Brain Injury Undergoing Emergency Craniotomy
Lead sponsor
Abd-elrahman hassan abd -elaziz
Phase
Observational
Overall status
Unknown status
Start date
July 23, 2020
Completion date
October 30, 2021
Enrollment
54 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative stress